Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-26 @ 10:42 AM
Study NCT ID:
NCT06840392
Status:
RECRUITING
Last Update Posted:
2025-10-31
First Post:
2025-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-20
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-17
First Submit QC Date:
None
Study First Post Date:
2025-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-30
Last Update Post Date:
2025-10-31
Last Update Post Date Type:
ESTIMATED